Aarca Research Inc., a healthcare and research technology company based in Orange, Connecticut, and Bangalore India, uses thermal videos of people’s faces to assess changes in arterial blood flow.
Utilizing machine learning models, this technology can predict early signs of diabetes before it is even diagnosed. “We are positioning ourselves as early detection technology for type 2- diabetes,” says Dr. Gayathri Choda, founder and CEO of Aarca Research Inc. Choda says their technology has already been validated in two multi-center clinical trials carried out in Hyderabad and Bangalore and has been incorporated in certain hospitals in Hyderabad, India. Their goal is to expand to more hospitals in the future.
The company’s early detection protocol is known as Intelligent Health Risk Assessment, a portable solution for on-site biometric health screenings. The input is a thermal video of the user and output is the real-time risk index. The technology includes computer vision, signal processing and machine learning models to calculate this risk. It identifies patients who show early indications of Type 2 Diabetes, Hypertension and Dyslipidemia. The software provides the severity of indicators on a scale of zero-ten (where zero is normal and ten is high) along with conclusions and next steps for each of the three diseases.
Users can share the report with a medical professional to get a detailed prevention and treatment plan. This screening is not a substitute for a regular physical examination by a medical professional, says the company.
Aarca Research has been granted the U.S. patent for “Non-invasive, non-contact system and method for measuring health parameters.”
